Candidaemia is associated with high mortality. In the last few years, several guidelines have been published on the management of Candida bloodstream infection. However, adherence to the practice guidelines has been suboptimal. In order to facilitate and objectively measure the adherence to good practice recommendations, a scoring criterion was published by the European Confederation of Medical Mycology (ECMM). The ECMM Quality (EQUAL) of Clinical Candidaemia Management is an audit tool that comprises of 10 quality indicators. Each quality indicator is allotted between 1 and 3 points. The maximum achievable score is 22 or 19 in patients with or without a central venous catheter, respectively. This paper reviews each of the 10 quality indicators and provides the context for improving quality within the individual domains. The review also suggests areas that are in need of further clarity or areas which merit attention in the future updates of the EQUAL scoring system so that clinicians are able to derive maximum benefit from the audit tool. The EQUAL scoring tool is an important milestone in the quality improvement aspect of the management of candidaemia and contributes to the various components of clinical governance in the management of Candida infection of the bloodstream.

中文翻译：

---

欧洲医学真菌学联合会临床念珠菌血症管理质量评分：基于积分的最佳实践建议的回顾

念珠菌血症与高死亡率有关。在过去几年中，关于念珠菌血流感染的管理已经发表了几项指南。然而，对实践指南的遵守并不理想。为了促进和客观地衡量对良好实践建议的遵守情况，欧洲医学真菌学联合会 (ECMM) 发布了评分标准。临床念珠菌血症管理的 ECMM 质量 (EQUAL) 是一种审核工具，包含 10 个质量指标。每个质量指标分配 1 到 3 分。在有或没有中心静脉导管的患者中，可达到的最高分分别为 22 或 19。本文回顾了 10 个质量指标中的每一个，并提供了在各个领域内提高质量的背景。审查还建议了需要进一步澄清的领域或在 EQUAL 评分系统的未来更新中值得关注的领域，以便临床医生能够从审计工具中获得最大收益。EQUAL 评分工具是念珠菌血症管理质量改进方面的一个重要里程碑，并有助于血液念珠菌感染管理中临床管理的各个组成部分。